Group One Trading’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABOS
Group One Trading's ABOS Position: Q3 2026 in Review
Group One Trading held its Acumen Pharmaceuticals (ABOS) position steady in Q3 2026 at 722 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7397.
Group One Trading first reported a position in ABOS in Q3 2022 and has held it in 16 quarters since. The position peaked at $304K in Q3 2024. 95 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.
- Group One Trading held 722 shares of Acumen Pharmaceuticals worth $1.6K as of Q3 2026.
- Group One Trading left its Acumen Pharmaceuticals share count unchanged in Q3 2026.
- Acumen Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7397 holding.
- Group One Trading first reported a position in Acumen Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- Group One Trading's Acumen Pharmaceuticals position peaked at $304K in Q3 2024.
- 95 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.